Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
As BPC-157 continues to be investigated, it represents an exciting potential shift in the treatment landscape of interstitial cystitis
Serious events (like severe pancreatitis or major liver issues) have been rare and similar to placebo so far, but long-term safety is still being monitored in ongoing phase 3 programmes
Symptoms that persist beyond the initial 812 weeks of therapy, worsen over time, or significantly impair nutritional intake warrant further evaluation
Standard injection technique says never to hit the same spot twice in a row
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
